All In Biotech

Free tool

FAERS Monitor: Flagyl I.V. Rtu In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018657 or its brand name (Flagyl I.V. Rtu In Plastic Container, Metronidazole). Reports on generic versions are filed under their own applications.

Reports

48,091

Serious

41,901

87% of reports

Hospitalization

19,836

Death reported

5,412

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,655
  • nausea3,458
  • off label use3,383
  • diarrhoea2,713
  • vomiting2,329
  • pyrexia2,288
  • headache2,258
  • abdominal pain2,119
  • pain2,119
  • fatigue1,959
  • dizziness1,684
  • condition aggravated1,634
  • dyspnoea1,595
  • acute kidney injury1,542
  • malaise1,467

Reports by year received

View as table
YearReports
2004459
2005480
2006482
2007511
2008320
2009676
2010858
20111,164
20121,431
20131,112
20141,451
20152,167
20162,469
20172,507
20184,185
20194,489
20203,817
20213,868
20223,400
20233,458
20243,160
20253,437
20262,187

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,006,068 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal1,5424.44.24,097
abdominal painSignal2,1194.03.84,796
pyrexiaSignal2,2882.92.82,884
condition aggravatedSignal1,6342.42.21,288
vomitingSignal2,3292.22.11,498
nausea3,4581.91.91,563
diarrhoea2,7131.81.81,071
off label use3,3831.71.6995
headache2,2581.61.5489
drug ineffective4,6551.51.5956
pain2,1191.51.4375
dizziness1,6841.51.4266
malaise1,4671.51.4219
dyspnoea1,5951.21.272
fatigue1,9591.11.119

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.